Leerink Partnrs Brokers Increase Earnings Estimates for THC

Key Points

• Leerink Partnrs raised their earnings estimates for Tenet Healthcare for Q3 2025 to $3.13 per share, significantly up from the previous estimate of $2.28.
• Tenet Healthcare's recent quarterly earnings of $4.02 per share surpassed the consensus estimate of $2.84, with a revenue of $5.27 billion also exceeding expectations.
• The stock currently holds a consensus rating of "Moderate Buy" with an average target price of $190.00, supported by multiple analysts upgrading their price targets recently.

Tenet Healthcare Corporation (NYSE:THC - Free Report) - Stock analysts at Leerink Partnrs boosted their Q3 2025 earnings per share estimates for Tenet Healthcare in a note issued to investors on Wednesday, July 23rd. Leerink Partnrs analyst W. Mayo now expects that the company will earn $3.13 per share for the quarter, up from their previous estimate of $2.28. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare's Q4 2025 earnings at $4.10 EPS, FY2025 earnings at $15.61 EPS, Q1 2026 earnings at $4.34 EPS, Q2 2026 earnings at $3.95 EPS, Q4 2026 earnings at $4.10 EPS, FY2026 earnings at $15.56 EPS, FY2027 earnings at $18.78 EPS, FY2028 earnings at $21.72 EPS and FY2029 earnings at $24.32 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, beating the consensus estimate of $2.84 by $1.18. The company had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. Tenet Healthcare had a return on equity of 24.69% and a net margin of 7.17%. Tenet Healthcare's revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.31 earnings per share.

A number of other analysts have also issued reports on THC. Morgan Stanley raised their price target on Tenet Healthcare from $175.00 to $210.00 and gave the stock an "overweight" rating in a research note on Monday, June 9th. Baird R W lowered Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. The Goldman Sachs Group raised their price target on Tenet Healthcare from $134.00 to $154.00 and gave the stock a "neutral" rating in a research note on Monday, May 5th. Bank of America raised their price objective on Tenet Healthcare from $165.00 to $180.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Finally, Raymond James Financial restated an "outperform" rating and issued a $200.00 price objective (up from $185.00) on shares of Tenet Healthcare in a report on Wednesday, July 23rd. Four investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $190.00.

Tenet Healthcare Price Performance

Shares of THC traded up $1.00 during trading hours on Monday, reaching $161.89. 200,416 shares of the company traded hands, compared to its average volume of 1,600,076. The stock has a fifty day simple moving average of $167.68 and a 200 day simple moving average of $145.78. The company has a quick ratio of 1.63, a current ratio of 1.71 and a debt-to-equity ratio of 2.39. Tenet Healthcare has a fifty-two week low of $109.82 and a fifty-two week high of $185.25. The stock has a market capitalization of $15.04 billion, a PE ratio of 10.36, a price-to-earnings-growth ratio of 0.67 and a beta of 1.64.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director James L. Bierman sold 13,836 shares of Tenet Healthcare stock in a transaction on Friday, May 23rd. The stock was sold at an average price of $159.58, for a total transaction of $2,207,948.88. Following the sale, the director owned 41,435 shares of the company's stock, valued at $6,612,197.30. The trade was a 25.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard W. Fisher sold 3,077 shares of Tenet Healthcare stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $165.72, for a total value of $509,920.44. Following the sale, the director directly owned 12,128 shares in the company, valued at $2,009,852.16. The trade was a 20.24% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 54,121 shares of company stock worth $8,846,305. 0.81% of the stock is owned by company insiders.

Institutional Trading of Tenet Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Caitong International Asset Management Co. Ltd raised its stake in shares of Tenet Healthcare by 2,227.3% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company's stock worth $45,000 after buying an additional 245 shares in the last quarter. First Citizens Bank & Trust Co. lifted its holdings in shares of Tenet Healthcare by 267.5% during the second quarter. First Citizens Bank & Trust Co. now owns 9,613 shares of the company's stock valued at $1,692,000 after purchasing an additional 6,997 shares during the last quarter. Exencial Wealth Advisors LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $200,000. Cullen Frost Bankers Inc. boosted its position in shares of Tenet Healthcare by 46.6% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 601 shares of the company's stock valued at $106,000 after purchasing an additional 191 shares during the period. Finally, Wallace Advisory Group LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $288,000. Institutional investors own 95.44% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.